409 related articles for article (PubMed ID: 18095921)
1. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of cannabinoid neuromodulators in symptom management.
Davis M; Maida V; Daeninck P; Pergolizzi J
Support Care Cancer; 2007 Jan; 15(1):63-71. PubMed ID: 17139494
[TBL] [Abstract][Full Text] [Related]
3. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
[TBL] [Abstract][Full Text] [Related]
5. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
Todaro B
J Natl Compr Canc Netw; 2012 Apr; 10(4):487-92. PubMed ID: 22491047
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
Jones SE; Durant JR; Greco FA; Robertone A
Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
[No Abstract] [Full Text] [Related]
8. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Levitt M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
[No Abstract] [Full Text] [Related]
9. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
Einhorn L
Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
[No Abstract] [Full Text] [Related]
10. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nausea and vomiting caused by cancer chemotherapy.
Laszlo J
Cancer Treat Rev; 1982 Dec; 9 Suppl B():3-9. PubMed ID: 6299552
[No Abstract] [Full Text] [Related]
14. Nabilone: an alternative antiemetic for cancer chemotherapy.
Dalzell AM; Bartlett H; Lilleyman JS
Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
[TBL] [Abstract][Full Text] [Related]
15. An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Priestman TJ; Priestman SG
Clin Radiol; 1984 Jul; 35(4):265-6. PubMed ID: 6329586
[TBL] [Abstract][Full Text] [Related]
16. Nabilone for the Management of Pain.
Tsang CC; Giudice MG
Pharmacotherapy; 2016 Mar; 36(3):273-86. PubMed ID: 26923810
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
Tafelski S; Häuser W; Schäfer M
Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Johansson R; Kilkku P; Groenroos M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
[No Abstract] [Full Text] [Related]
19. Study design for the evaluation of the efficacy and safety of nabilone.
Stark P
Cancer Treat Rev; 1982 Dec; 9 Suppl B():35-7. PubMed ID: 6299553
[No Abstract] [Full Text] [Related]
20. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
